
Join to View Full Profile
UTHealth-Houston (Stroke Institute)6410 Fannin St. Ste 1010Houston, TX 77030
Phone+1 713-500-7092
Fax+1 713-500-7101
Dr. Savitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 2001 - 2004
- Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2000 - 2001
- Albert Einstein College of MedicineClass of 2000
Certifications & Licensure
- TX State Medical License 2007 - 2026
- MA State Medical License 2004 - 2007
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Vascular Neurology
Clinical Trials
- Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients Start of enrollment: 2009 Jan 01
- Safety of Intravenous Thrombolysis for Wake-up Stroke Start of enrollment: 2010 Jul 01
- Mesenchymal Stromal Cells for Ischemic Stroke Start of enrollment: 2016 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- MarkVCID2 Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics.Steven M Greenberg, Marylin S Albert, Hongyu An, Konstantinos Arfanakis, Arnold M Evia
Annals of Neurology. 2025-09-22 - Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial.Mya C Schiess, Jessika Suescun, Juan D Martinez-Lemus, Charles Green, Tia S Thomas
Movement Disorders. 2025-09-01 - Video-based Intervention to Reduce Treatment and Outcome Disparities in Adults Living with Stroke or Transient Ischemic Attack (VIRTUAL): protocol for a randomized con...Munachi Okpala, Chigozirim Izeogu, Mengxi Wang, Charles Green, Gabretta Cooksey
Trials. 2025-08-12
Abstracts/Posters
- Assessment and Reduction of Unnecessary Thrombophilia Testing in Patients 18-60 Years with Acute Cryptogenic Ischemic StrokeSean.I. Savitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Cell Society 2nd Annual Clinical MeetingMedical Education Advocates, Coronado, California - 2/17/2012
- DiscussantHouston, TX - 2/13/2014
Other
- Locked-in syndromeSavitz SI, Caplan LR
http://www.uptodate.com/contents/locked-in-syndrome
UpToDate, Wolters Kluwer Health - 2013-03-07
Press Mentions
- Study on New Telerehabilitation Stroke Therapy Model Led by UTHealth Houston for Underserved Community in the Texas Rio Grande ValleyFebruary 18th, 2025
- Athersys Provides MultiStem Clinical UpdateJanuary 9th, 2023
- Sharrief Awarded $3.1M NIH Grant to Test Whether Telehealth Improves Racial Disparities in Outcomes for Stroke SurvivorsDecember 6th, 2021
- Join now to see all
Grant Support
- Center for Clinical and Translational SciencesUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2024–2031
- Gulf Regional Area Stroke Program and OklahomaUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2018–2028
- Multiethnic Validation of VCID biomarkers in South TexasUNIVERSITY OF TEXAS HLTH SCIENCE CENTER2021–2026
- Neurodegenerative Changes in Post-Stroke DepressionUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2022–2025
- Cytoprotection With Autologous Mononuclear Cells For StrokeNational Institute Of Neurological Disorders And Stroke2011–2012
- Safety/Feasibility Of Autologous Mononuclear Bone Marrow Cells In Stroke PatientsEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2011
- Career DevelopmentNational Institute Of Neurological Disorders And Stroke2008–2011
- Preclinical Development Of Bone Marrow Mononuclear Cell Therapy For Ischemic StroNational Institute Of Neurological Disorders And Stroke2008–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: